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Précis (limit = 50 words; words = 41) 
We demonstrated that differences in the composition of n-3 and n-6 polyunsaturated 
fatty acids, excluding eicosapentaenoic or docosahexaenoic acid, were able to influence the 
Th1/Th2 balance of lymphocytes in humans as well as in mice, even with normal habitual 
dietary intake.  
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ABSTRACT (limit = 250 words; words = 238) 
Background: It has become increasingly clear that polyunsaturated fatty acids (PUFAs) 
have immunomodulatory effects. However, the intake of these fatty acids used in animal 
studies often is greatly in excess of dietary human intake. Whether differences in the 
composition of fatty acids that are consumed in amounts consistent with normal habitual 
dietary intake can influence immune function remains uncertain. 
Methods: We manufactured 3 types of liquid diet, related to modified fatty acid composition 
(n-6/n-3 = 0.25, 2.27 and 42.9), but excluding eicosapentaenoic acid and docosahexaenoic 
acid, based upon a liquid diet used clinically in humans. We assessed CD3-stimulated 
cytokine production of splenocytes in female BALB/c mice (n=4 per group) fed one of three 
liquid diets for 4 w. We also measured the cytokine production of peripheral blood 
mononuclear cells stimulated with phorbol myristate acetate and ionomycin in humans at the 
end of a 4-week period of consumption of two different liquid diets (n-6/n-3 = 3 and  44).  
Results: We found that the ratio of interferon- (IFN- / interleukin-4 (IL-4) was 
significantly higher in mice fed the n-3 rich diet than in others. In humans, IFN- / IL-4 was 
significantly higher after the n-3 versus the n-6 enhanced diet. 
Conclusions: Differences in the composition of n-3 and n-6 PUFAs induces a shift in the 
Th1/Th2 balance in both mouse and human lymphocytes, even when ingested in normal 
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BACKGROUND 
Environmental factors in the Western lifestyle probably contribute to the development 
of atopy and allergies. A decrease in saturated fatty acid consumption and an increase in 
polyunsaturated fatty acid (PUFA) consumption in the diet have been linked to the increased 
prevalence of atopic diseases in industrialized countries1. PUFAs are classified as n–3 or n–6, 
on the basis of the location of the last double bond relative to the terminal methyl ( end of 
the molecule. The intake of PUFAs results in uptake into essentially every cell of the body, 
where they bind fatty acid–binding proteins and undergo metabolic conversion2. There are 2 
PUFAs: linoleic acid (LA, 18:2 n–6) and -linolenic (ALA, 18:3 n–3), which cannot be 
synthesized de novo by human cells and, hence, have been designated as essential fatty acids. 
These essential fatty acids undergo a series of saturation, de-saturation, and elongation steps 
that can result in the formation of long-chain PUFAs. Common dietary sources of n–6 PUFAs 
are corn, safflower, soybean, and sunflower oils3. LA is converted to arachidonic acid (AA, 
20:4  n–6) which, along with other PUFAs (including some n–3 fatty acids), can serve as the 
precursor for the eicosanoid mediators of inflammation (prostaglandins, thromboxanes, and 
leukotrienes). ALA, which is obtained from green leafy vegetables, walnuts, and rapeseed and 
flaxseed oils, can be further elongated, although not very efficiently, to long-chain 
eicosapentaenoic acid (EPA, 20:5 n–3) 4. Most of the long chain n–3 PUFAs, EPA, and 
docosahexaenoic acid (DHA, 22:6 n–3) are obtained directly from the dietary intake of marine 
fish oils. Typical Western diets contain almost 10 times more LA (n-6) than ALA (n-3) 5. In 
Japan, the prevalence of atopic diseases has been rising, which has been paralleled by a 
decrease in the ratio of n-3 to n-6 PUFA consumption. Conversely, epidemiologic studies in a 
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population of coastal Eskimos have revealed that a high intake of n-3 PUFAs correlates with a 
low incidence of cardiovascular and inflammatory diseases, like asthma and type I diabetes 
mellitus6. 
It has become increasingly clear that PUFAs have immune-modulating effects in cell 
culture and in vivo 7-10. PUFAs can modulate cytokine  production, lymphocyte proliferation, 
surface molecule expression, phagocytosis, and apoptosis, and they can inhibit natural killer 
cell activity 11-19. In general, n–3 PUFAs are considered good for human health, whereas n–6 
PUFAs are deemed less beneficial or even harmful3. Although studies are not conclusive and 
there have been conflicting reports 20, the n–3 PUFAs appear to decrease specific disease 
symptoms and the need for anti-inflammatory drugs among patients with chronic 
inflammatory diseases7,21. In addition, n–3 fatty acids may act as immunosuppressive agents 
for a variety of inflammatory disorders, including Crohn’s disease, atherosclerosis, colitis, 
graft-versus-host disease, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma, and 
systemic lupus erythematosus22-31.  
Animal feeding studies have indicated that a high intake of n-6 and n-3 fatty acid can 
influence lymphocyte functions and cell-mediated immunity. The impact of dietary fatty acids 
on animal autoimmune disease models appears to depend upon the animal model and the type 
and amount of fatty acid that the animals are fed32. The weight-relative intake of these fatty 
acids used in animal studies often is greatly in excess of that achievable in humans33. 
Consequently, the results of studies involving human autoimmune disease have been less 
dramatic, even though human trials have been subject to uncontrolled dietary and genetic 
backgrounds, infection and other environmental influences, and their basic trial designs have 
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been inadequate32. Nonetheless, large long-term differences in the habitual intake of these 
fatty acids might influence immune function.  
Recently, many types of enteral nutrient solutions have been developed that are being 
used for chronically ill patients, as a long-term source of nutrition. There is considerable 
variety in the fatty acid composition of these liquid diets; some contain a large amount of n-6 
PUFAs, and others more n-3. In this two-part study, we first investigated the effects of dietary 
fatty acid on T-lymphocyte polarization in mice using three such liquid diets, all the same 
composition except for fatty acid content.  Second, we examined whether differences in the 
fatty acid composition of two otherwise similar (but not identical) liquid diets affect the 
Th1/Th2 polarization of lymphocytes in human patients receiving long-term enteral nutrition. 
 
MATERIALS AND METHODS 
Animal experiments 
To determine whether the composition of fatty acids in a habitual diet affects Th1/Th2 
polarization, we fed three separate groups of female BALB/c mice (n=4 per group) one of 
three different liquid diets for 4 weeks. These diets were manufactured by modifying the fatty 
acid composition of a liquid diet used clinically for patients, without changing the 
composition of any other component, including its nutrients, electrolytes, calories (1 kcal /ml) 
and vitamins (Table 1). Each liquid diets contained 1.96g/100kcal oil. In addition, Diet A 
contained perilla seed oil (n-6/n-3= 0.25, n-3 rich); Diet B contained 28% perilla seed oil and 
72% corn oil (n-6/n-3= 2.27, n-3 enhanced) and Diet C contained corn oil (n-6/n-3= 42.9, n-6 
rich) (Table 2).  
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After 4 weeks, mononuclear cells were isolated from the spleen of each mouse. 96-well 
round-bottomed micro-culture plates were coated with 10 g/ml of purified anti-mouse 
CD3monoclonal Ab (Cedarlane, Ontario Canada), followed by three washes with Hanks 
solution. Cells were cultured (at a concentration  of 2 x 106 /ml) in quadruplicate cultures at 
37℃ in 5% CO2 in RPMI 1640 medium containing antibiotics, 1mM L-glutamine, 5 x10 –5M  
2-mercaptoethanol (ME), and 10% FCS , for 24h. The production of interferon- (IFN- and 
interleukin-4 (IL-4)  in the culture supernatant was measured by ELISA in triplicate, using an 
AN’ALYZATM Immunoassay System (mouse IFN-and IL-4) supplied by TECHNE Co. 
(Minneapolis, MN55413, USA).  
Animal experiments were conducted in accordance with the guidelines of the Animal 
Care and Use Committee of Nagasaki University School of Medicine. During the observation 
period, mice were housed under standard, approved conditions. 
 
Clinical study 
Ten patients with neurodegenerative disorders or in the chronic stages of a 
cerebrovascular accident (CVA) who were being fed exclusively through an enteral tube were 
enrolled in this study (Table 3).  Fully informed consent was obtained from the each patient or 
from an appropriate family member. The institutional review board had approved the project 
prior to subject recruitment. 
 
Using a cross-over design composed of two sequential four-week observation periods, 
we gave each patient enteral feeding formula RAC (Racol; n-6/n-3 = 3, EN Otsuka, Japan) for 
     - 8 -
 
                                                             
4 weeks, either preceded or followed by four weeks of EL (Ensure Liquid; n-6/n-3 = 44, 
Abbott Japan Co., Ltd.). The RAC formula contained a combination of perilla, soybean, palm 
oil and medium-chain triglyceride as its source of lipids; meanwhile, among these four fatty 
acid ingredients, EL contained corn oil exclusively (Table4). Both formulae contained ALA, 
but not EPA or DHA. For the duration of each 4-week period, water intake and total calories 
(1200 to1600 kcal) remained unchanged for any given patient, and no other nutrition was 
given.  
Blood samples were taken at the end of each 4-week observation period. Peripheral 
blood mononuclear cells (PBMCs) were isolated from whole blood using density gradient 
centrifugation, and then washed twice with Hanks’ balanced salt solution. PBMCs (2 x 105 
/well) were cultured in RPMI 1640 medium containing 10% FBS, antibiotics, and L-
glutamine, with phorbol myristate acetate (PMA: 20ng/ml) and ionomycin (500ng/ml) in 
200l in 96-well flat-bottomed plates. After 24hrs of culture at 37℃ in 5% CO2, the culture 
supernatant was removed for cytokine assay. The production of IFN- and IL-4 in the culture 
supernatant was measured by ELISA in triplicate, using an AN’ALYZATM Immunoassay 
System (Human IFN- and IL-4) supplied by TECHNE Co. (Minneapolis, MN55413, USA). 
 
Statistical analysis 
All values were calculated as means ± SD. The results of cytokine assays were done in 
triplicate with SDs of < 10 %. Inter-group differences in the animal experiments were tested 
for statistical significance using Fisher’s PLSD test, and those in the clinical study by 
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Wilcoxon rank sign test. A difference of p< 0.05 was considered statistically significant, and 




In the animal experiment, there was no significant inter-group difference in body weight 
between the 3 groups of mice at the end of the feeding: group A (fed Diet A, n-3 rich diet) 
weighed 22.8 ± 1.0 g; group B( fed Diet B, n-3 enhanced diet) 23.6 ±2.1g; group C (fed Diet 
C, n-6 rich diet) 23.5± 2.0g.  
Production of IFN by anti-CD3-stimulated splenocytes declined significantly in the 
mice fed the n-6 rich diet (Diet C) relative to that observed in the mice fed n-3 rich Diet A 
(Fig. 1a; p=0.0097).  Production of IL-4 by splenocytes in mice fed the n-3 rich Diet A or the 
n-6 rich Diet C was significantly reduced relative to mice fed Diet B (Fig. 1b; p = 0.0044 and 
0.0245, respectively). As a result, the ratio of IFN- to IL-4 was significantly higher in the 




During the 8 weeks of observation, 4 patients developed fever or some other 
inflammatory sign(s) and were excluded from the study. We ultimately analyzed the 
production of IFN- and IL-4 by PBMCs from only 6 patients who had had 4 weeks of 
consumption of both the n-3 enhanced diet and the n-6 rich diet, in the absence of fever or 
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other signs of inflammation. The clinical characteristics of these 6 patients are shown in Table 
3. Three patients were fed the n-3 enhanced diet (RAC) during the first 4 week period, before 
crossing over to the alternative n-6 rich diet (EL); and the other 3 patients received the same 
two diets, but in the reverse order. 
The production of IFN- by PBMCs stimulated with PMA and ionomycin increased in 
2 and decreased in 4 patients during their four weeks being fed the n-6 rich diet (Fig. 2).  The 
production of IL-4 by PBMCs rose more in every patient while on the n-6 rich diet than on the 
n-3 enhanced diet (Fig. 2; p = 0.0277). As a result, the ratio of IFN- to IL-4, which may be a 
better index of actual Th1/Th2 cytokine-production, was significantly higher during 
consumption of the  n-3 versus the n-6 rich diet (Fig. 2; p = 0.0277). 
 
DISCUSSION 
In the present study, we demonstrated that liquid diets with different compositions of n-
3 and n-6 PUFAs are able to induce a shift in the Th1/Th2 balance of lymphocytes in both 
humans and mice, even when administered in normal dietary amounts. The fact that an n-3 
rich diet containing ALA, in the absence of DHA and EPA (marine fish oil), still modulated 
immune function is another important finding.  
In vitro and animal feeding studies have suggested that PUFAs have the capacity to 
modulate lymphocyte functions and cell-mediated and antibody responses to various 
challenges. However, the quantities of fatty acid administered to animals in these studies often 
were greatly in excess of the relative dietary intake of humans. In our own animal experiment, 
we fed mice one of 3 different liquid diets, different only in their fatty acid content. Because 
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these liquid diets were formed based on the composition of a liquid diet (RAC) commonly 
used clinically in humans, the amount of fatty acid was not excessive for mice. Nevertheless, 
the ratios of Th1 to Th2 cytokine production were strikingly different between the 3 groups of 
mice.  
 Although previous animal studies have demonstrated that diets rich in n-3 PUFA can 
exert anti-inflammatory and immunomodulatory effects in vivo, there have been relatively few 
good studies in humans. In the present clinical study, we used 2 different liquid diets that are 
clinically available in Japan. Accordingly, the two fluid supplements were different in several 
nutrients other than fatty acids; however, these differences are minimal (Table 4) because both 
liquid diets are formulated to satisfy well-established daily nutrient requirements. Moreover, 
the differences in the other nutrients paled next to the sizeable differences in fatty acid 
content, so that we believe that it was the difference in fatty acid composition that induced the 
change of Th1/ Th2 balance of lymphocytes we observed.  Admittedly, we could be wrong; it 
is possible that the small differences in vitamin and trace mineral content could have 
influenced immune function, but we think that unlikely.   
Other investigators have speculated that the ratio of n–3 to n–6 may be an important 
factor in the modulation of inflammation and autoimmunity34. Increasing the ratio of n–3 to n–
6 relieves symptoms associated with some inflammatory diseases35, although this may not 
hold true in all cases36. 
Our observation seems to be accordance with previous animal studies, which  have 
generated considerable evidence that feeding animals either plant or fish oils rich in n-3 
PUFAs does alter the ex vivo production of cytokines, like tumor necrosis factor (TNF), 
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interleukin 1 (IL-1), interleukin 6(IL-6 )and interleukin 2(IL-2). The n-6 PUFA, arachidonic 
acid, gives rise to the eicosanoid family of inflammatory mediators (prostaglandins, 
leukotrienes and related metabolites), whereas n-3 PUFAs act as arachidonic acid antagonists. 
However, it remains to be seen which mechanism(s) led to the immunomodulation observed 
in the present study. We did not investigate which fatty acid contributed to the change in 
Th1/Th2 ratio or which immune cells were central to that process.  
In the present study, each liquid diet contained ALA as the only source of n-3 fatty acids, 
albeit at different doses. It is believed that ALA has immunomodulatory effects that are 
similar to those of EPA and DHA, although its effect seems to be much weaker. It is not clear 
how EPA, DHA and other metabolites contributed to the present results, because we did not 
investigate to what extent ALA was elongated in vivo. Only a few studies have investigated 
the immunologic effects of the precursor, n–3 PUFA ALA, in humans. Caughey et al 37 
reported that 13.7 g ALA /d for 4 weeks results in a decrease in production of TNF- and IL-
1 by endotoxin-stimulated mononuclear cells of 27% and 30%, respectively. By comparison, 
fish oil providing 2.7 g EPA+DHA/d decreased production of these cytokines by 70% and 
78%, respectively37. Given that roughly one fifth the weight of EPA+DHA produced 
approximately twice the decline in cytokine production as ALA, long-chain n–3 PUFAs 
appear to be about 9-10 times as potent as ALA with respect to the inhibition of cytokine 
production in healthy subjects. In contrast, several studies using lower intakes of ALA (2–9.5 
g/d) did not identify effects on TNF-, IL-1, or IL-6 production by endotoxin-stimulated 
mononuclear cells38-40 or on IL-2, IL-4, or IFN production by mitogen-stimulated 
mononuclear cells39. These data suggest that increasing ALA intake to >10 g/d is required for 
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anti-inflammatory or immunomodulatory effects to be seen. Even then, the effects will be 
much more modest than those exerted by long-chain n–3 PUFAs 37 .  In fact, only Diet A, 
which contained a large amount of ALA, appeared to suppress the Th2 response and enhance 
the Th1 response in the current animal study. Meanwhile, Diet B, corresponding to RAC, 
contributed less to IFN production. 
Of note is that our patients received, at most, only 1.8-2.4g ALA/d during the 4-week 
period in which they were fed the n-3 enhanced diet. Nevertheless, the Th1/Th2 balance in 
PBMCs shifted to Th1, even though we only assessed TCR-stimulated cytokine production.  
Apparently, the present clinical study differs from previous ones in several respects, which 
include the total fat amount, subject characteristics, and methods of immunologic evaluation. 
In particular, our subjects were not healthy; rather, they were chronically ill patients with a 
neurological disorder, which itself may affect lymphocyte function. In addition, all patients 
depended on long-term enteral nutrition, which may have altered ALA metabolism. Tanaka et 
al. 41 reported that the same liquid diet (RAC) used in the present study induce significant 
increases in the serum concentration of EPA, DPA and DHA, as well as ALA. Their patients 
also had severe motor and intellectual disabilities and relied on long-term enteral nutrition for 
all of their nutritional needs. 
Albeit preliminary, our findings suggests that liquid diets rich in n-3 PUFAs can be of 
use in the treatment of immunological or inflammatory disorders. Human trials, designed to 
control for dietary and genetic background and other environmental influences, clearly are 
warranted to formally assess the therapeutic potential of n-3 rich diets. 
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Table 1. Composition of the liquid diets for the animal experiment 
 
Ingredients  Diet A Diet B Diet C 
Perilla oil (g/100ml) 1.96 0.50 - 
Corn oil  - 1.46 1.96 









Minerals ( /100ml) Na, 73.8mg; K,138mg; Ca, 44.0mg; Mg,19.3mg; P, 
44mg;  Cl, 117mg; Fe, 625g; Zn, 640g; Mn, 
133g; Cu, 125g 
Vitamines ( /100ml) Retinol, 207IU; Cholecalciferol, 13.6IU; 
-Tocopherol acetate, 650g; 
Phytonadione,62.5g; Thiamine, 380g; 
Riboflavin, 245g; Pyridoxine,375g; 
Cyanocobalamine,0.32g; Ascorbic acid, 28mg; 




100 100 100 
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Table 2. Fatty acid composition of the experimental liquid diets. 
 
 Diet A Diet B Diet C 
C8:0                                (%) 36.9       38.1 38.2 
C16:0 (Palmitic acid)       (%) 5.3 7.6 8.5
C18:0 (Stearic acid)         (%) 1.9 2.1 2.2 
C18:1 (Oleic acid)            (%) 9.5 17.8 20.2 
C18:2 (Linoleic acid)       (%) 9.4 24.1 30.1
C18:3 （-Linolenic acid）(%) 37.0 10.6 0.7 
n-6 / n-3 0.25 2.27 42.9 
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Table 3. Characteristics of the subjects. 
Patient   Sex Age Disease 1st  4 wk / 2nd 4wk 
1               F 89 Cerebral hemorrhage EL / RAC 
2 F 75 Multi-system atrophy EL / RAC
3 F 55 Parkinson’s diseaese EL / RAC 
4 F 75 Corticobasal degeneration RAC / EL 
5 F 83 Parkinson’s diseaese RAC / EL 
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Table 4. Composition of the diets for the clinical study (per 100mL) 
 
Component Racol (RAC) Ensure Liquid (EL) 
Energy(kcal)                      
(protein / fat / carbohydrate ) 





   Casein protein (g) 3.4 3.4 
   Soy protein (g) 1.7 0.5 
Fat   
   Medium-chain triglyceride (mg) 750 0
   Myrstic acid (mg) 0 14.1 
Palmitic acid (mg) 269 415.4 
Stearic acid (mg) 72 84.5 
Oleic acid (mg) 342 929.3
Linoleic acid (mg) 450 1992.3 
-Linolenic acid (mg) 150 45.8 
Arachidonic acid (mg) 0 21.1 
n-6 fatty acid (mg) 450 2013.4
n-3 fatty acid (mg) 150 45.8 
n-6/n-3 3 44 
Carbohydrate (g) 15.6 13.7 
Vitamins and trace elements 
Vitamin A (IU) 207 250 
Vitamin E (mg) 0.7 3 
Vitamin C (mg) 28.1 15.2 
Folate (g) 37.5 20
Vitamin B6 (mg) 0.4 0.2 
Vitamin B12 (g) 0.3 0.6 
Fe (mg) 0.6 0.9 
    Cu  (mg) 0.1 0.1
    Mn  (mg) 0.1 0.2 
    Zn  (mg) 0.6 1.5 
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Figure legends 
 
Fig.1  Production of cytokines of splenocytes stimulated with anti-CD3 in the mice fed, n-3 
rich diet(Diet A) , n-3 enhanced diet (Diet B), or n-6 rich diet (Diet C).  a; production of 
interferon- ( IFN-b; production of interleukin-4(IL-4), c; ratio of IFN-/ IL-4. The 
results of cytokine assays were in triplicate with SDs of < 10 %. * signifies p< 0.05 
(Fisher’s PLSD test).  
 
Fig.2  Production of cytokines of peripheral blood mononuclear cells stimulated with phorbol 
myristate acetate and ionomycin in the patients at the end of each 4-week observation period 
of feeding with n-3 enhanced diet (Racol) and n-6 rich diet(Ensure Liquid).  a; production of 
interferon- ( IFN-b; production of interleukin-4(IL-4), c; ratio of IFN- / IL-4. The 
results of cytokine assays were in triplicate with SDs of < 10 %.  * signifies  p< 0.05 
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